RMD Insight, LLC Report issue

For profit Phase 1
Founded: Seattle WA United States (2012)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2016
NCT02673255
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

Tetanus and diphtheria toxoids adsorbed (Decavac) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diphtheria (Phase 1)

Tetanus (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1